Effects of specific nutrients on immune modulation in patients with gastrectomy
- PMID: 32021954
- PMCID: PMC6992678
- DOI: 10.1002/ags3.12299
Effects of specific nutrients on immune modulation in patients with gastrectomy
Abstract
Gastric cancer (GC) is one of the most prevalent and lethal malignant neoplasms worldwide. The main treatment for GC is gastrectomy, which generally causes considerable metabolic stress to patients. To modulate cell function, maintain homeostasis of the immune response, reduce postoperative complications, and obtain favorable outcomes, physicians prescribe specific nutrients with immunomodulatory properties as supplementation to enteral or parenteral formulas, indicating immunonutrition. In the formulas, among the immunonutrients, glutamine, arginine, and n-3 polyunsaturated fatty acids are the most commonly used either alone or in combination. The present review summarizes and focuses on the evidence obtained from clinical trials and animal studies supporting the role of immunonutrients supplemented enterally or parenterally in total or subtotal gastrectomy. In addition, this review describes the possible molecular mechanisms underlying the protective action of these immunonutrients, which may contribute to therapeutic approaches to improve postoperative outcomes of gastrectomy. Combination of conventional therapy with immunonutrition seems to be a useful strategy to achieve synergistic effects in the treatment of GC patients.
Keywords: arginine; gastrectomy; glutamine; immunonutrition; n‐3 fatty acids.
© 2019 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterological Surgery.
Conflict of interest statement
Conflicts of Interest: Authors declare no conflicts of interest for this article.
Similar articles
-
Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition.World J Surg. 2009 Sep;33(9):1815-21. doi: 10.1007/s00268-009-0140-1. World J Surg. 2009. PMID: 19629583 Clinical Trial.
-
The use of immunonutrition in burn injury care: where are we?J Burn Care Res. 2010 Sep-Oct;31(5):677-91. doi: 10.1097/BCR.0b013e3181eebf01. J Burn Care Res. 2010. PMID: 20671563 Review.
-
Prospective randomized trial of preoperative enteral immunonutrition followed by elective total gastrectomy for gastric cancer.Br J Surg. 2012 May;99(5):621-9. doi: 10.1002/bjs.8706. Epub 2012 Feb 24. Br J Surg. 2012. PMID: 22367794 Clinical Trial.
-
Rational base and clinical results of immunonutrition.Minerva Anestesiol. 2000 May;66(5):362-6. Minerva Anestesiol. 2000. PMID: 10965717 Review.
-
Immunonutrition in surgical patients.Curr Drug Targets. 2009 Aug;10(8):771-7. doi: 10.2174/138945009788982432. Curr Drug Targets. 2009. PMID: 19702523 Review.
Cited by
-
A meta-analysis of randomized controlled trials comparing enteral immunonutrition (EIN) and standard enteral nutrition regarding biochemical, immunological, and clinical outcomes in gastrectomy patients with gastric cancer and investigating evidence networks for EIN formulae.Wideochir Inne Tech Maloinwazyjne. 2023 Dec;18(4):588-602. doi: 10.5114/wiitm.2023.133439. Epub 2023 Dec 4. Wideochir Inne Tech Maloinwazyjne. 2023. PMID: 38239588 Free PMC article.
-
Efficacy of disitamab vedotin in non-small cell lung cancer with HER2 alterations: a multicenter, retrospective real-world study.Front Oncol. 2024 Nov 6;14:1441025. doi: 10.3389/fonc.2024.1441025. eCollection 2024. Front Oncol. 2024. PMID: 39568568 Free PMC article.
-
Immunonutrition in Operated-on Gastric Cancer Patients: An Update.Biomedicines. 2024 Dec 18;12(12):2876. doi: 10.3390/biomedicines12122876. Biomedicines. 2024. PMID: 39767782 Free PMC article. Review.
-
De-Ubiquitinating Enzymes USP21 Regulate MAPK1 Expression by Binding to Transcription Factor GATA3 to Regulate Tumor Growth and Cell Stemness of Gastric Cancer.Front Cell Dev Biol. 2021 Mar 15;9:641981. doi: 10.3389/fcell.2021.641981. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33791299 Free PMC article.
-
Clinical Effect of Tumor-Specific Total Nutrients in Patients with Adjuvant Chemotherapy After Radical Gastric Cancer Resection: A Randomized Controlled Trial.J Gastrointest Cancer. 2024 Jun;55(2):845-851. doi: 10.1007/s12029-024-01029-3. Epub 2024 Feb 11. J Gastrointest Cancer. 2024. PMID: 38342837 Free PMC article. Clinical Trial.
References
-
- Slade MS, Simmons RL, Yunis E, Greenberg LJ. Immunodepression after major surgery in normal patients. Surgery. 1975;78(3):363–72. - PubMed
-
- Mortensen K, Nilsson M, Slim K, Schäfer M, Mariette C, Braga M, et al. Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations. Br J Surg. 2014;101(10):1209–29. - PubMed
-
- Mazaki T, Ebisawa K. Enteral versus parenteral nutrition after gastrointestinal surgery: a systematic review and meta‐analysis of randomized controlled trials in the English literature. J Gastrointest Surg. 2008;12(4):739–55. - PubMed
-
- Gramlich L, Kichian K, Pinilla J, Rodych NJ, Dhaliwal R, Heyland DK. Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition. 2004;20(10):843–8. - PubMed
-
- Wu MH, Lin MT, Chen WJ. Effect of perioperative parenteral nutritional support for gastric cancer patients undergoing gastrectomy. Hepatogastroenterology. 2008;55(82–83):799–802. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous